PharmAthene Gets $113M Lost Profits Award In SIGA Spat
A Delaware Chancery Court judge ruled on Wednesday that SIGA Technologies Inc. must pay PharmAthene Inc. $113.1 million for the expected profits PharmAthene would have earned from selling SIGA's smallpox drug...To view the full article, register now.
Already a subscriber? Click here to view full article